Skip to content

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Amivantamab plus chemotherapy vs. chemotherapy in participants with EGFR-mutant advanced non-small cell lung cancer after progression on osimertinib: a MARIPOSA-2 analysis of the Asian subgroup

Background The Phase 3 MARIPOSA-2 study showed that amivantamab, a bispecific antibody with immune cell-directing activity, plus chemotherapy significantly improved progression-free survival (PFS) compared with chemotherapy alone in participants with common epidermal growth factor receptor (EGFR)-mutated non-small cell...

J.-Y. Shih, Jie Wang, Yong-Sheng Wang et al. · 0 citations
Open access Aug 2026

Expression, prognostic association, and immune microenvironment correlates of C4orf50 in breast cancer: a The Cancer Genome Atlas Breast Invasive Carcinoma (TCGA-BRCA) bioinformatics study

Background Chromosome 4 open reading frame 50 (C4orf50) is a poorly characterized gene whose expression pattern and clinical relevance in breast cancer remain unclear. We aimed to evaluate the expression, prognostic association, immune microenvironment correlates, and transcriptional features associated with C4orf50 in...

Si-Hang Lin, Li-Xia Liu, Jia-Yu Guan et al. · 0 citations
Open access 2026

Long-term impact of robot-assisted training on walking pattern reconstruction in chronic stroke survivors: insights from multiparametric gait analysis.

AIMS To determine whether robot-assisted lower-limb training promotes superior walking pattern reconstruction in chronic stroke survivors, as quantified by multiparametric gait analysis and supported by concurrent improvements in motor, balance, and functional outcomes. METHODS In this retrospective observational stu...

Zu-Jie Qin, Qin-Hua Cao, Jie Wang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.